- GlobeNewswire•3 hours ago
Five-Year Data from the Medtronic ENGAGE Registry Demonstrate Durable, Consistent, and Proven Outcomes in Real-World Setting
Presented at Charing Cross, Five-Year Clinical Data from Global ENGAGE Registry Support Endurant II`s Market-Leading Position Worldwide DUBLIN and LONDON - April 26, 2017 - Medtronic plc (NYSE:MDT) today ...
New Medtronic Data Demonstrate Clinical and Quality of Life Benefits for VenaSeal Closure System in Venous Reflux Disease Patients
Three-Year VeClose Trial and One-Year WAVES Study Data Presented at Charing Cross DUBLIN and LONDON - April 25, 2017 - Medtronic plc (NYSE: MDT) today announced three-year outcomes from the VeClose U.S. ...
Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients
DUBLIN and LONDON - April 25, 2017 - Medtronic plc (NYSE: MDT) today reinforced consistent results for its IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with two new sub-analyses from the IN.PACT Global ...
MDT: Summary for Medtronic plc. Ordinary Shares - Yahoo Finance
Medtronic plc (MDT)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
|Day's range||82.07 - 82.97|
|52-week range||69.35 - 89.27|
Trade prices are not sourced from all markets
|PE ratio (TTM)||28.99|
|Dividend & yield||1.72 (2.14%)|
|1y target est||N/A|